A
-
Abdelhamid, Dalia
Design, synthesis in vitro and in vivo evaluation of new diaryltriazoles carboxylic and hydroxamic acid derivatives as inhibitors of tumor necrosis alpha converting enzyme (TACE) [Volume 2, Issue 1, 2023, Pages 44-62]
-
Abourhma, Gamal
Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]
-
Aly, Omar
Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]
-
Aly, Omar
Design, synthesis in vitro and in vivo evaluation of new diaryltriazoles carboxylic and hydroxamic acid derivatives as inhibitors of tumor necrosis alpha converting enzyme (TACE) [Volume 2, Issue 1, 2023, Pages 44-62]
B
-
Badran, Mostafa M.
Design, synthesis in vitro and in vivo evaluation of new diaryltriazoles carboxylic and hydroxamic acid derivatives as inhibitors of tumor necrosis alpha converting enzyme (TACE) [Volume 2, Issue 1, 2023, Pages 44-62]
D
-
Diamanduros, Andrew
Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]
E
-
El-Abasawy, Nasr M.
Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method. [Volume 2, Issue 1, 2023, Pages 1-10]
-
EL-Olemy, Ahmed
Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method. [Volume 2, Issue 1, 2023, Pages 1-10]
F
-
Fouad, Ali
Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method. [Volume 2, Issue 1, 2023, Pages 1-10]
H
-
Hassan, Abdelfattah
Design, synthesis in vitro and in vivo evaluation of new diaryltriazoles carboxylic and hydroxamic acid derivatives as inhibitors of tumor necrosis alpha converting enzyme (TACE) [Volume 2, Issue 1, 2023, Pages 44-62]
-
Hassan, Heba A.
Design, synthesis in vitro and in vivo evaluation of new diaryltriazoles carboxylic and hydroxamic acid derivatives as inhibitors of tumor necrosis alpha converting enzyme (TACE) [Volume 2, Issue 1, 2023, Pages 44-62]
K
-
King, Stephen
Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]
R
-
Ramadan, Ahmed Mohammed
A potential therapy for the Rheumatoid Arthritis: New drug discovery [Volume 2, Issue 1, 2023, Pages 11-20]
S
-
Salsbury, Freddie
Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]
-
Saraya, Roshdy elsayed
Review article on instrumental analysis of Molnupiravir, Favipiravir, and Ritonavir in different matrices [Volume 2, Issue 1, 2023, Pages 36-43]
-
Scarpinato, Karin
Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]
-
Sharaf El-din, Mohamed M.
Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method. [Volume 2, Issue 1, 2023, Pages 1-10]
Your query does not match with any item